The aim of our study was to ultilize combined radiomcis features extracted from T2-weighted MRI images as quantitative imaging biomarkers to differentiate neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS). Twenty-nine NMOSD patients and forty-five MS patients were enrolled. Our study showed 61 radiomics features and 8-feature-based radiomics signature were significantly different between NMOSD and MS. Therefore, radiomics may be an newly useful method which provides a promising non-invasive way of differentiating NMOSD and MS.
This abstract and the presentation materials are available to members only; a login is required.